Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 9/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 5/20 | 0.46 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL839937 | 0.99 | SCN9A (0.47) | SCN9AKCNH2SCN5AROCK2ADRA2A | |
| SCHEMBL8823813 | 0.85 | ADRA2A (0.39) | SCN9AKCNH2SCN5AADRA2AADRA2B | |
| SCHEMBL8823817 | 0.85 | ADRA2A (0.39) | SCN9AKCNH2SCN5AADRA2AADRA2B | |
| Ammonia Solution, Strong SCHEMBL3672627 | 0.85 | SCN9A (0.49) | SCN9AKCNH2SCN5AADRA2AMAOA | |
| SCHEMBL839693 | 0.83 | SCN9A (0.38) | SCN9AKCNH2SCN5ACYP19A1 | |
| SCHEMBL841717 | 0.83 | SCN9A (0.50) | SCN9AKCNH2SCN5AADRA2AMAOA | |
| SCHEMBL841245 | 0.83 | SCN9A (0.43) | SCN9AKCNH2SCN5AROCK2MAOA | |
| Ammonia Solution, Strong SCHEMBL3674494 | 0.82 | SCN5A (0.37) | SCN9AKCNH2SCN5A | |
| SCHEMBL841364 | 0.80 | SCN5A (0.38) | SCN9AKCNH2SCN5A | |
| Ammonia Solution, Strong SCHEMBL3674959 | 0.80 | SCN9A (0.35) | SCN9AKCNH2SCN5ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | disclosed |